KURA
Price
$6.91Alerts
Change
-$0.44 (-5.99%)
Updated
Nov 20 closing price
Capitalization
646.74M
97 days until earnings call
Intraday BUY SELL Signals
TARS
Price
$72.91Alerts
Change
-$4.76 (-6.13%)
Updated
Nov 20, 04:59 PM (EDT)
Capitalization
3.21B
102 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KURA vs TARS

KURA vs TARS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KURA vs. TARS commentary
Nov 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a Hold and TARS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for KURA with price predictions
Nov 19, 2026

KURA's RSI Indicator ascends from oversold territory

The RSI Oscillator for KURA moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In 32 of the 33 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 64 cases where KURA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Momentum Indicator moved above the 0 level on November 19, 2026. You may want to consider a long position or call options on KURA as a result. In 64 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

Following a +11.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where KURA advanced for three days, in 211 of 268 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

KURA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for KURA turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 31 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KURA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for KURA entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. KURA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.354) is normal, around the industry mean (3.596). P/E Ratio (-2.157) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (12.821) is also within normal values, averaging (443.347).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KURA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TARS with price predictions
Nov 19, 2026

TARS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for TARS turned positive on November 10, 2026. Looking at past instances where TARS's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on TARS as a result. In 58 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.

TARS moved above its 50-day moving average on November 11, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TARS crossed bullishly above the 50-day moving average on November 18, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.

Following a +4.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where TARS advanced for three days, in 230 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Bearish Trend Analysis

The 10-day RSI Indicator for TARS moved out of overbought territory on November 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 22 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 61%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TARS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

TARS broke above its upper Bollinger Band on November 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TARS entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.258) is normal, around the industry mean (3.596). TARS has a moderately low P/E Ratio (-64.112) as compared to the industry average of (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (5.498) is also within normal values, averaging (443.347).

The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. TARS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
KURA vs TARS: Fundamental Ratings
KURA
TARS
OUTLOOK RATING
1..100
1724
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
10018
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
8042
P/E GROWTH RATING
1..100
1576
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARS's Valuation (3) in the null industry is significantly better than the same rating for KURA (81) in the Biotechnology industry. This means that TARS’s stock grew significantly faster than KURA’s over the last 12 months.

TARS's Profit vs Risk Rating (18) in the null industry is significantly better than the same rating for KURA (100) in the Biotechnology industry. This means that TARS’s stock grew significantly faster than KURA’s over the last 12 months.

TARS's SMR Rating (94) in the null industry is in the same range as KURA (99) in the Biotechnology industry. This means that TARS’s stock grew similarly to KURA’s over the last 12 months.

TARS's Price Growth Rating (42) in the null industry is somewhat better than the same rating for KURA (80) in the Biotechnology industry. This means that TARS’s stock grew somewhat faster than KURA’s over the last 12 months.

KURA's P/E Growth Rating (15) in the Biotechnology industry is somewhat better than the same rating for TARS (76) in the null industry. This means that KURA’s stock grew somewhat faster than TARS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KURATARS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
82%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
COMPARISON
Comparison
Nov 21, 2026
Stock price -- (KURA: $7.35 vs. TARS: $77.67)
Brand notoriety: KURA and TARS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 82% vs. TARS: 99%
Market capitalization -- KURA: $646.74M vs. TARS: $3.21B
KURA [@Biotechnology] is valued at $646.74M. TARS’s [@Biotechnology] market capitalization is $3.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 1 FA rating(s) are green while TARS’s FA Score has 2 green FA rating(s).

  • KURA’s FA Score: 1 green, 4 red.
  • TARS’s FA Score: 2 green, 3 red.
According to our system of comparison, TARS is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 5 TA indicator(s) are bullish while TARS’s TA Score has 5 bullish TA indicator(s).

  • KURA’s TA Score: 5 bullish, 3 bearish.
  • TARS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KURA is a better buy in the short-term than TARS.

Price Growth

KURA (@Biotechnology) experienced а -1.08% price change this week, while TARS (@Biotechnology) price change was +1.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.90%. For the same industry, the average monthly price growth was -16.46%, and the average quarterly price growth was -27.70%.

Reported Earning Dates

KURA is expected to report earnings on Feb 25, 2027.

TARS is expected to report earnings on Mar 02, 2027.

Industries' Descriptions

@Biotechnology (-8.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

TARS and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARS has been loosely correlated with PTGX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TARS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARS
1D Price
Change %
TARS100%
+2.26%
PTGX - TARS
42%
Loosely correlated
-2.47%
BLTE - TARS
40%
Loosely correlated
-3.33%
MGTX - TARS
39%
Loosely correlated
-2.16%
ARVN - TARS
39%
Loosely correlated
-0.37%
KURA - TARS
38%
Loosely correlated
+0.14%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DRV20.080.98
+5.13%
Direxion Daily Real Estate Bear 3X ETF (DRV)
SMCZ9.700.38
+4.08%
Defiance Daily Target 2X Short SMCI ETF (SMCZ)
SPBW28.61-0.29
-1.02%
AllianzIM Buffer20 Allocation ETF
BUFG28.61-0.44
-1.51%
FT Vest Buffered Allocation Growth ETF (BUFG)
FDLO72.86-1.25
-1.69%
Fidelity Low Volatility Factor ETF (FDLO)